Zhang et al. elucidated that Gubenyiliu II exerted anti-tumor growth and anti-metastatic effects on breast cancer model by decreasing heparanase and growth factor expression, which subsequently led to suppressing ERK/AKT pathways. Here, AKT1 is linked to breast carcinoma.